erdafitinib
janssen
['urothelial', 'erdafitinib', 'blcsm']
erdafitinib confers os benefit in fgfr-altered urothelial cancer #asco23 #asco2023 #blcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.